Further research suggests that manipulating nuclear acetyl-CoA metabolism through enhancing nuclear-localized Acetyl-CoA synthetase 2 (ACSS2) or inhibiting ATP-citrate lyase (ACLY), to epigenetically reprogram terminal exhausted cells, improves anti-tumor responses (232). This evidence concerns the gene ACLY and neoplasm.